Hotter B, Padberg I, Liebenau A, et al. Identifying unmet needs in long-term stroke care using in-depth assessment and the Post-Stroke Checklist – The Managing Aftercare for Stroke (MAS-I) study. Eur Stroke J 2018; 3(3): 237–245.
In this article Tables 1, 3 and 4 are incorrect. The correct tables are printed below:
Table 1.
Domains explored, according assessments and cut-off measures used to define significant deficit.
| Domains | Assessment | Cut-Offs used | Reference |
|---|---|---|---|
| Self reported need | Post Stroke Checklist (PSC) | >0 points | 38 |
| Quality of life | EuroQoL (EQ-5D-3L) | – | 40 |
| Overall function | Modified Rankin Scale (mRS)Barthel-Index (BI) | – | 41,42 |
| Spasticity | Modified Ashworth Scale (mAS) in REPAS system | mAS 3 or 4 in at least 1 joint | 36,37 |
| Post Stroke Pain | PainDetect | >12 points | 43 |
| Aphasia | Partial Aachen Aphasia Test (Token Test) | >3 points | 44 |
| Cognitive deficits | Montreal Cognitive Assessment | <26 points | 45 |
| Depression | Hamilton Depression Scale (HAMD-17) | >8 points | 46 |
| Secondary Prevention | Morisky Medication Adherence scale (MMAS) | >2 points | 47,50,51 |
| Social needs | Nikolaus score for evaluation of social conditions (SoS) | <17 points | 48 |
| Caregiver burden | Burden Scale for Family Caregivers | >9 points | 49 |
Use of the ©MMAS is protected by US copyright laws. Permission for use is required. A license agreement is available from: Donald E. Morisky, ScD, ScM, MSPH, Professor, Department of Community Health Sciences, VCLA School ofPublic Health, 650 Charles E. Young Drive South, Los Angeles, CA 90095-1772.
Table 3.
Clinical and patient-reported outcome measures at assessment and recommendations by stroke specialist.
| Total | |
|---|---|
| n (%) | 57 (100) |
| Current mRS | 2 (1–3) |
| Delta mRS | 0 (0–1) |
| Current BI | 95 (80–100) |
| PROM scales | |
| EQoL-5D IV | 0.81 (0.70–1.00) |
| EQoL-5D VAS | 70 (50–85) |
| Any need in PSC (score > 0) | 54 (95) |
| Affected according to validated scales, n (%) | |
| Significant spasticity (mAS) | 20 (35) |
| Neuropathic pain (PD) | 1 (2) |
| Social needs (Nikolaus) | 10 (18) |
| Morisky Medication Adherence scale (MMAS) | 8 (14) |
| Speech impairment (TT) | 5 (9) |
| Cognitive deficits (MoCA) | 34 (61) |
| Depression (HD17) | 11 (20) |
| Caregiver (BSFC) | 6 (24) |
| Affected according to any of these scales | 51 (90) |
| n deficits according to these scales, median (IQR) | 2 (1–2) |
| Patient reported FU, n (%) | |
| BP management | 51 (91) |
| Cognition screening | 26 (46) |
| Depression screening | 21 (37) |
| Spasticity management | 19 (58) |
| Fall management and prevention | 21 (84) |
| Recovery of mobility | 46 (92) |
| Recovery of walking | 42 (88) |
| Recovery-assistive ULF | 37 (84) |
| Recovery functional ULF | 31 (69) |
| Family support available | 48 (92) |
| Access further therapies | 46 (92) |
| Social needs counselling | 31 (60) |
| Stop smoking assistance | 7 (54) |
| Management of malnutrition | 7 (44) |
| Stroke specialist recommendations, n (%) | |
| Medical review | 17 (30) |
| Change in medication | 10 (18) |
| Rehabilitation | 4 (7) |
| Outpatient therapy | 27 (47) |
| Social worker intervention | 19 (33) |
| n recommendations per patient, median (IQR) | 1 (0.5–2) |
FU: follow-up; ULF: upper limb function; BI: Barthel Index; EQoL-5D EuroQuol; mRS: modified Rankin Scale; BP: blood pressure; PROM: patient-reported outcome measure; IV: index value; VAS: Visual Analogue Scale; PSC: Post-Stroke Checklist; TT: token test; PD: PainDetect; HD17: Hamilton Depression Scale 17 Items; MoCA: Montreal Cognitive Assessment; mAS: modified Ashworth Scale, Nikolaus Social Situation score, MMAS Morisky Medication Adherence Scale; BSFC: Burden Scale for Family Caregivers.
Numbers given are presented as median (interquartile range (IQR)) if not specified otherwise.
Use of the ©MMAS is protected by US copyright laws. Permission for use is required. A license agreement is available from: Donald E. Morisky, ScD, ScM, MSPH, Professor, Department of Community Health Sciences, VCLA School ofPublic Health, 650 Charles E. Young Drive South, Los Angeles, CA 90095-1772.
Table 4.
Association of quality of life as measured by EuroQoL and clinical deficits as well as the sensitivities, specificities; negative and positive predictive values of the PSC to detect stroke-related health problems as measured by validated scales.
| EuroQoL-5D | TT | PD | HD17 | MoCA | mAS | Nikolaus | MMAS | BSFC |
|---|---|---|---|---|---|---|---|---|
| Index Value | 0.926 | 0.405 | 0.131 | 0.121 | 0.008 | 0.017 | 0.723 | 0.067 |
| VAS | 0.288 | 0.173 | 0.092 | 0.289 | 0.051 | <0.001 | 0.596 | 0.116 |
|
PSC item (clinical scale compared) |
Sens |
Spec |
PPV |
NPV |
p |
|||
| Spasticity (mAS) | 0.55 | 0.64 | 0.46 | 0.72 | 0.260 | |||
| Pain (PD) | 1.00 | 0.33 | 0.11 | 1.00 | 1.000 | |||
| Communication (TT) | 0.40 | 0.79 | 0.15 | 0.93 | 0.319 | |||
| Mood (HD17) | 0.91 | 0.71 | 0.44 | 0.97 | <0.001 | |||
| Cognition (MoCA) | 0.38 | 0.27 | 0.45 | 0.22 | 0.015 | |||
| Life after Stroke (Nikolaus) | 0.90 | 0.60 | 0.32 | 0.97 | 0.005 | |||
| Family Relationship (BSFC) | 0.50 | 0.95 | 0.75 | 0.86 | 0.031 | |||
| Any PSC item (any need on clinical scale) | 0.94 | 0 | 0.89 | 0 | 1.000 | |||
VAS: Visual Analogue Scale; TT: token test; PD: PainDetect; HD17: Hamilton Depression Scale 17 Items; MoCA: Montreal Cognitive Assessment; mAS: modified Ashworth Scale, Nikolaus Social Situation score, MMAS: Morisky Medication Adherence scale MMAS; BSFC: Burden Scale for Family Caregivers; PSC: Post-Stroke Checklist; Sec.: secondary; ADL: activities of daily living; Sens.: sensitivity; Spec.: specificity; PPV: positive predictive value; NPV: negative predictive value.
Numbers given are p values obtained by Fisher’s exact test unless otherwise specified. For the PROM PSC Items associations were calculated where there are corresponding scales in the clinical scales.
Use of the ©MMAS is protected by US copyright laws. Permission for use is required. A license agreement is available from: Donald E. Morisky, ScD, ScM, MSPH, Professor, Department of Community Health Sciences, VCLA School ofPublic Health, 650 Charles E. Young Drive South, Los Angeles, CA 90095-1772.
In this article, references 50 and 51 are missing. They are listed below:
50. Krousel-Wood MA, Islam T, Webber LS, et al. New Medication Adherence Scale Versus Pharmacy Fill Rates in Seniors With Hypertension. Am J Manag Care 2009; 15: 59–66.
51. Morisky DE and DiMatteo MR. Improving the measurement of self-reported medication nonadherence: Final response. J Clin Epidemio 2011; 64: 258–263.